Lawmakers in New York continue to debate legislation that seeks to legalize medical cannabis for qualified patients. Meanwhile, opponents of this compassionate and common sense measure argue that acknowledging the known therapeutic benefits of cannabis and protecting those who could benefit from its use inexplicably “exploits” the seriously ill.

Unlike medi-pot opponents, I actually interact with cannabis patients. Often, they seek me out — writing me testimonials like the one below. Perhaps if more politicians and, God forbid, members of law enforcement shared in these sort of one-on-one interactions, they’d change their tune. Or perhaps, they would do what Presidential hopeful John McCain did, and simply turn their backs.

Letters for June 16, 2008
via The Oneonta Daily Star

Marijuana works as a medicine

Kudos for your editorial support in favor of legally protecting patients who use cannabis therapy under the guidance of their physician (”Medical marijuana makes sense,” June 7).

While authoring the recent publication, “Emerging Clinical Applications for Cannabis and Cannabinoids: A Review of the Scientific Literature” (NORML Foundation 2008), I reviewed more than 150 clinical and preclinical studies assessing the therapeutic value of cannabis and its active compounds to treat symptoms — and in some cases moderate disease progression — in a variety of illness, including multiple sclerosis, Alzheimer’s, osteoporosis, diabetes and Lou Gehrig’s disease. Nearly all of the studies cited in my work were published within the past eight years.

Unlike many politicians and law enforcement officials, I frequently interact with medical marijuana patients. Many of them write to me daily, as do their physicians. Often they tell me stories like this: “I was recently diagnosed with a malignant brain tumor inside the left temporal lobe of my brain. I had surgery, and I’ve just started chemotherapy and radiation. The surgeon actually apologized for the fact that he could not write me a prescription for marijuana, but he told me it was safe to smoke. … Marijuana is saving my life right now; it has helped to kill my seizures, nausea, dizziness, and calm my headaches. If marijuana can help me with all my other problems in addition to possibly reducing the size of my tumor and extending my life, then why on earth would our government not allow me to have it?”

Why indeed?

Paul Armentano

Washington, D.C.

Armentano is deputy director of NORML and the NORML Foundation. 

Television ads in favor of pending medical cannabis legislation are now airing in select markets of New York state. To view the ad, click here. To learn more about what you can do to support efforts to legalize medical marijuana in New York, please click here.

Study: Marijuana potency increases in 2007
via Associated Press

WASHINGTON (AP) — Marijuana potency increased last year to the highest level in more than 30 years, posing greater health risks to people who may view the drug as harmless, according to a report released Thursday by the White House.

The latest analysis from the University of Mississippi’s Potency Monitoring Project tracked the average amount of THC, the psychoactive ingredient in marijuana, in samples seized by law enforcement agencies from 1975 through 2007. It found that the average amount of THC reached 9.6 percent in 2007, compared with 8.75 percent the previous year.

The 9.6 percent level represents more than a doubling of marijuana potency since 1983, when it averaged just under 4 percent.

“Today’s report makes it more important than ever that we get past outdated, anachronistic views of marijuana,” said John Walters, director of the White House Office of National Drug Control Policy. He cited baby boomer parents who might have misguided notions that the drug contains the weaker potency levels of the 1970s.

“Marijuana potency has grown steeply over the past decade, with serious implications in particular for young people,” Walters said. He cited the risk of psychological, cognitive and respiratory problems, and the potential for users to become dependent on drugs such as cocaine and heroin.

While the drug’s potency may be rising, marijuana users generally adjust to the level of potency and smoke it accordingly, said Dr. Mitch Earleywine, who teaches psychology at the State University of New York in Albany and serves as an adviser for marijuana advocacy groups. “Stronger cannabis leads to less inhaled smoke,” he said.

The White House office attributed the increases in marijuana potency to sophisticated growing techniques that drug traffickers are using at sites in the United States and Canada.

…

“The increases in marijuana potency are of concern since they increase the likelihood of acute toxicity, including mental impairment,” said Dr. Nora Volkow, director of the National Institute on Drug Abuse, which funded the University of Mississippi study.

When I was in journalism school, the rule of thumb was that you needed to have your facts confirmed by three separate sources before a news story was ‘fit to print.’ By that standard, the ‘three sources’ cited in the story above — White House Drug Czar (and chronic liar) John Walters, NIDA’s (US National Institute on Drug Abuse) Potency Monitoring Project, and Nora Volkow, who heads the rabidly anti-drug propaganda agency that paid for the Monitoring Project study — don’t even add up to one.

Fortunately, the AP did at least demonstrate the good sense to speak with SUNY Albany Professor (and NORML Advisory Board member) Mitch Earleywine, who stated the obvious factoid overlooked by the White House: As the potency of pot rises, people simply smoke less of it. Mitch could have also noted that most cannabis consumers actually prefer less potent pot, just as the majority of those who drink alcohol prefer beer or wine over hard liquor. Or he could have mentioned how doctors may legally prescribe a FDA-approved non-toxic pill that contains 100 percent THC, and curiously, nobody at NIDA or at the Drug Czar’s office seems particularly concerned about it. Strangely, AP writer Hope Yen felt the need to identify Dr. Earleywine, who has authored numerous peer-reviewed studies and books on various aspects of cannabis, as “an adviser for marijuana advocacy groups,” but felt no such need to identify Mr. Walters or Ms. Volkow as “those who favor arresting and jailing adults who use marijuana, even when their use is for medical purposes.”

Of course, in an effort to get to the bottom of the so-called “potent pot” story, Ms. Yen might have thought to inquire why the US National Drug Intelligence Center’s 2007 National Drug Threat Assessment states, “Most of the marijuana available in the domestic drug markets is lower potency commercial-grade marijuana.” Geez, you’d think that the various prohibitionist branches of the US government would at least get their stories straight!

Oh well, since lying about the alleged dangers of allegedly more potent pot is now an annual tradition (Remember “Pot 2.0” anybody?), there’s always next year.

Barney Frank is a man of courage.

This longtime NORML ally is sponsoring legislation in Congress to allow for the medical use of marijuana, and to strip the federal government of their power to criminalize the possession and use of pot by adults.

In the video below, provided by Tom Gregory at Huffington Post, Frank explains why he believes, “There should be no federal laws against the personal use of marijuana, whether it’s for medical purposes or not.”

Hear, hear! 

So here’s an interesting ruling from the New York Court of Appeals finding that the possession of small amounts of pot in prison does not constitute “dangerous contraband” under state law.

NY court: Small amount of marijuana in prison not a felony
via The Associated Press

ALBANY, N.Y. (AP) — New York’s top court says small amounts of marijuana in prison do not represent “dangerous contraband” under the law and ordered lower courts to reduce two convictions to misdemeanors with shorter sentences.

…The court majority says the test for “dangerous contraband” is its likelihood to be used in a way that causes death, injury, escape or “other major threats” to prison safety or security. 

Naturally, this ruling raises the question: If cannabis can not be legally defined as “dangerous contraband” when it’s possessed in prison, then how can it be legally defined as “dangerous contraband” when it is possessed by responsible adults inside their own homes?

Sounds to me like it’s time for another lawsuit.

Below is this week’s summary of pending state legislation and tips to help you become involved in changing the laws in your state.

California: While early returns indicate a narrow margin of victory for Mendocino’s Measure B — which seeks to repeal the county’s eight-year-old law allowing adults to possess up to 25 marijuana plants — final results may not be available for several weeks. Opponents of the measure are expected to challenge Measure B. They argue that the provision directly conflicts with a recent state District Court of Appeals decision that prohibits municipalities from imposing limits on the quantity of marijuana patients may possess under state law.

Rhode Island: State activists are encouraged to attend a lobby day at the State House on June 11. The lobby day is sponsored by The Rhode Island Patient Advocacy Coalition, which is backing legislation to establish state-licensed medical cannabis distribution centers. The Rhode Island Senate previously approved the measure, and advertisments in support of the House bill are now playing in various markets. To learn more about this effort, please visit NORML’s online advocacy system.

New York: Television ads in favor of pending medical cannabis legislation began airing this week in select markets of New York state. To view the ad, click here. To learn more about what you can do to support efforts to legalize medical marijuana in New York, please click here.

I’ve said this before but it bears repeating. The endocannabinoid system is involved in the regulation of a broad range of primary biological functions in humans — including appetite, mood regulation, blood pressure, bone density, reproduction, learning capacity, and motor coordination.

Shutting down this system in order to lose a few vanity pounds is likely not a good idea — and, in fact, is a pretty effective way to kill mice.

It’s arguably not a healthy option for humans either.

UK drug body: Sanofi’s Acomplia linked to five deaths
via CNN

Sanofi-Aventis S.A.’s (SNY) anti-obesity pill Acomplia has been linked to five deaths and 720 adverse reaction since its U.K. launch in 2006, according to a document posted on the U.K. drug regulator’s website Tuesday.

One of the deaths was due to suicide, said the Medicines and Healthcare products Regulatory Agency, or MHRA, document, which recorded adverse side effects up until May 9.

The drug, a new kind of obesity treatment that blocks certain brain receptors that regulate appetite, last year was rejected by a panel of U.S. Food and Drug Administration experts on concerns that the drug increases the number of psychiatric events like depression and suicidal thinking among users.

… Despite withdrawing its application to market the drug in the U.S., where it was to have been known as Zimulti, Sanofi-Aventis has plans to resubmit it to the FDA and other regulators in 2009 for approval as a treatment for type 2 diabetes.

In a study released in 2006, Acomplia showed promise as a diabetes treatment after patients who took the pill for a year reported improvements in blood sugar control and cholesterol along with modest weight loss.

However, a recent study of the drug in obese heart patients found more than 40% of those who took the drug developed psychiatric problems, while another study, published last month, raised concerns about using drugs like Acomplia in children.  

Ever wonder why the studies purporting to ‘prove’ marijuana’s health risks only recruit subjects who smoke pot 24 hours a day, seven days a week?

Heavy marijuana use shrinks brain parts
via Reuters  

Brain scans showed the hippocampus and amygdala were smaller in men who were heavy marijuana users compared to nonusers.  … The men had smoked at least five marijuana cigarettes daily for on average 20 years.    

The answer: If they didn’t, there wouldn’t be any purported risks left to write about.

I mean, seriously, imagine if these scientists had tried recruiting 15 subjects who drank at least five shots of vodka every day for 20 years? That is, if they could find 15 subjects who were still alive.

Marijuana may up heart attack, stroke risk
via Reuters

Heavy marijuana use can boost blood levels of a particular protein, perhaps raising a person’s risk of a heart attack or stroke, U.S. government researchers said on Tuesday. …The marijuana users in the study averaged smoking 78 to 350 marijuana cigarettes per week.

The study did not look at whether the heavy marijuana users actually had heart disease. 

So here we go again. Three-hundred and fifty joints per week?! Who are these people? And what’s with the caveat at the end of the story? If the purpose of the study is to assess whether there might be a link between ridiculously heavy pot use and heart disease, then why not, you know, look to see whether the subjects actually suffered from heart disease? (Likely answer: Aside from the abnormal protein level, the patients were probably otherwise healthy.)

Bottom line: smoking pot all day, every day probably isn’t good for you (though I find it interesting that, even among the most prolific pot users, most of the herb’s purported dangers are either speculative or are only apparent on hyper-sensitive brain scans and multi-tiered neurocognitive tests). Fortunately, 99.9 percent of pot smokers don’t behave this way.

And no, it’s not prohibition that curbs their use habits; it’s the recognition that too much pot is not conducive to an otherwise healthy, responsible lifestyle (just as pounding five shots a day wouldn’t be conducive to, well, life).

So what lesson can be learned from the two studies above (aside from the fact that our government has no interest in investigating the health of ordinary cannabis consumers)? It’s that pot, like alcohol, is best consumed in moderation, and that pot prohibition — even when compared to the excessive use of the drug itself — still poses the greatest threat to health.

Below is this week’s summary of pending state legislation and tips to help you become involved in changing the laws in your state.

California: The state Assembly approved Assembly Bill 2279 this week by a vote of 42-29. The measure now awaits action by the Senate. If passed, AB 2279 would protect patients from employment discrimination on the basis of their state-licensed medical cannabis use in off-work hours. Californians are strongly encouraged to contact their Senators via NORML’s online advocacy system.

California: Voters in Northern California’s Mendocino County will decide on Tuesday whether or not to repeal an eight-year old county law (The Personal Use of Marijuana Initiative, also known as Measure G) which legalized the possession and use of up to 25 marijuana plants. Measure B, a Mendocino County-wide ballot initiative, seeks to overturn the measure. Activists are also challenging the validity of Measure B in court, arguing that a recent state District Court of Appeals decision prohibits municipalities from imposing limits on the quantity of marijuana patients may possess under state law. To learn more about efforts opposing Measure B, please visit California NORML or No on B.

Vermont: Legislation seeking to establish licensing procedures for state farmers who wish to commercially cultivate industrial hemp became law this week. However, as amended, House Bill 267 will not take effect until “such time as the United States Congress amends the definition of ‘marihuana.’”

North Carolina: Legislation seeking to establish a task force to study options for regulating the legal use of medical marijuana for qualified patients was introduced this week and referred to the House Committee on Health. As introduced, House Joint Resolution 2405 would “study whether a public benefit would be derived from making it lawful for physicians to prescribe and patients to possess and use marijuana.” Residents in North Carolina are strongly encouraged to contact their House Members via NORML’s online advocacy system.  

I’m proud to be a guest on this week’s edition of KPFT’s Century of Lies radio program to discuss the therapeutic use of cannabis and the federal government’s multi-decade campaign to suppress research documenting its clinical utility. You can listen to the radio show online here.

You can also watch a separate interview with me discussing the anti-cancer properties of pot, and join the ongoing discussion on Alternet.org here.

“This ain’t your grandfather’s or your father’s marijuana. This will hurt you. This will addict you. This will kill you.”– Mark R. Trouville, DEA Miami, speaking to the Associated Press (June 22, 2007)

Having spent over a decade debunking the ‘potent pot myth‘ — the false yet wildly popular notion that today’s cannabis is dramatically more potent, and thus more dangerous (or as British Prime Minister Gordon Brown likes to say, “more lethal“) than the marijuana of the 1960s, 70s, and 80s, it’s nice to finally get some back up.

Writing in the forthcoming issue of the scientific journal Addiction, researchers at the University of New South Wales, National Drug and Alcohol Research Centre, examined the potency of over 100,000 pot seizures from around the word. They concluded (drum roll please), “Claims made in the public domain about a 20- or 30-fold increase in cannabis potency and about the adverse mental health effects of cannabis contamination are not supported currently by the evidence.”

The investigators also addressed the equally popular myth that ‘potent pot’ is responsible for an increase in the number of people seeking ‘treatment’ for cannabis, finding, “Another reason for increase in treatment seeking could be the introduction of cannabis diversion programmes, some of which involve mandatory treatment for those who have committed a cannabis-related offense” — a point we’ve made here on several occasions.

Want more details? NORML podcaster extraordinaire Russ Belville has an extensive summary of the study here.